title: Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.
abstract: The immune response is critical in determining the outcome of hepatitis C virus (HCV) infection. Interleukin (IL)-18 is a pivotal mediator of the Th1/Th2-driven immune response. Two IL-18 promoter polymorphisms (-607C/A and -137G/C) and their haplotypes were known to affect IL-18 expression. We examined the role played by these polymorphisms in determining HCV clearance or persistence. Genotyping was performed among African American injection drug users with HCV clearance (n = 91) or HCV persistence (n = 182) and among European Americans with hemophilia who were mainly infected through plasma transfusion. Among injection drug users, IL18 -607A (odds ratio [OR], 3.68 [95% confidence interval {CI},1.85-7.34]) and IL18 -137C (OR, 2.33 [95% CI, 1.24-4.36]) were significantly associated with HCV clearance. A haplotype carrying -607A and -137C (OR, 4.53 [95% CI, 1.77-11.6]) was also strongly associated with viral clearance. No association was found among those with hemophilia. These results suggest that IL18 promoter polymorphism may affect the outcome of HCV infection in certain groups.
authors.affiliation: Laboratory of Genomic Diversity, Science Applications International Corportation-Frederick, MD, USA.
authors.forename: Ping
authors.initials: P
authors.lastname: An
authors.forename: Chloe L
authors.initials: CL
authors.lastname: Thio
authors.forename: Gregory D
authors.initials: GD
authors.lastname: Kirk
authors.forename: Sharyne
authors.initials: S
authors.lastname: Donfield
authors.forename: James J
authors.initials: JJ
authors.lastname: Goedert
authors.forename: Cheryl A
authors.initials: CA
authors.lastname: Winkler
mesh_terms: D000328:Adult; D001741:Black or African American; D044383:Black People; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D005838:Genotype; D006239:Haplotypes; D006467:Hemophilia A / Q000150:complications; D016174:Hepacivirus / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000235:genetics* / Q000276:immunology / Q000821:virology; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics; D020382:Interleukin-18 / Q000235:genetics* / Q000276:immunology; D008297:Male; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D015819:Substance Abuse, Intravenous / Q000150:complications; D044465:White People
chemical_list: D020382:Interleukin-18
references.citation: Science. 2004 Aug 6;305(5685):872-4
references.pmid: 15297676
references.citation: Arthritis Res Ther. 2006;8(3):R60
references.pmid: 16563174
references.citation: World J Gastroenterol. 2005 Mar 21;11(11):1594-8
references.pmid: 15786533
references.citation: Immunity. 1999 Sep;11(3):359-67
references.pmid: 10514014
references.citation: Am J Hum Genet. 1995 Mar;56(3):799-810
references.pmid: 7887436
references.citation: Hepatobiliary Pancreat Dis Int. 2002 Aug;1(3):378-82
references.pmid: 14607710
references.citation: Allergy. 2005 Jul;60(7):900-6
references.pmid: 15932380
references.citation: Circulation. 2005 Aug 2;112(5):643-50
references.pmid: 16043644
references.citation: Annu Rev Immunol. 2001;19:423-74
references.pmid: 11244043
references.citation: J Neuroimmunol. 2001 Jan 1;112(1-2):146-52
references.pmid: 11108943
references.citation: Hepatology. 1999 Sep;30(3):787-93
references.pmid: 10462387
references.citation: J Immunol. 1997 Oct 15;159(8):3961-7
references.pmid: 9378984
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):985-90
references.pmid: 17215375
references.citation: Tissue Antigens. 2003 Dec;62(6):498-504
references.pmid: 14617033
references.citation: Biochem Biophys Res Commun. 2005 Dec 16;338(2):736-41
references.pmid: 16243298
references.citation: Biochem Biophys Res Commun. 2006 Apr 21;342(4):1413-6
references.pmid: 16516851
references.citation: J Leukoc Biol. 2003 Feb;73(2):213-24
references.pmid: 12554798
references.citation: Hepatology. 2007 Mar;45(3):623-30
references.pmid: 17326156
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2367-72
references.pmid: 10681432
references.citation: JAMA. 1998 Jan 7;279(1):35-40
references.pmid: 9424041
references.citation: Genes Immun. 2004 Jun;5(4):294-300
references.pmid: 15071492
references.citation: Sarcoidosis Vasc Diffuse Lung Dis. 2005 Jun;22(2):105-13
references.pmid: 16053025
references.citation: DNA Cell Biol. 2002 Aug;21(8):561-9
references.pmid: 12215259
references.citation: J Med Virol. 2003 Aug;70(4):588-93
references.pmid: 12794721
references.citation: Annu Rev Biochem. 1997;66:807-22
references.pmid: 9242925
references.citation: Science. 2004 Aug 6;305(5685):786-7
references.pmid: 15297654
references.citation: Biochem J. 1995 May 15;308 ( Pt 1):197-202
references.pmid: 7755566
references.citation: Genes Immun. 2005 Jun;6(4):347-57
references.pmid: 15815689
references.citation: Genes Immun. 2007 Mar;8(2):91-9
references.pmid: 17215860
references.citation: N Engl J Med. 1989 Oct 26;321(17):1141-8
references.pmid: 2477702
references.citation: J Hepatol. 2003 Feb;38(2):230-6
references.pmid: 12547413
references.citation: Nat Genet. 2004 Dec;36(12):1312-8
references.pmid: 15543147
references.citation: Clin Exp Allergy. 2003 Aug;33(8):1097-102
references.pmid: 12911784
references.citation: J Infect Dis. 2001 Jul 1;184(1):16-21
references.pmid: 11398104
references.citation: Hepatology. 2003 Mar;37(3):590-9
references.pmid: 12601357
references.citation: Lancet. 1995 Oct 14;346(8981):1006-7
references.pmid: 7475549
references.citation: J Virol. 2002 May;76(10):4792-7
references.pmid: 11967296
references.citation: Ann Clin Lab Sci. 2005 Autumn;35(4):415-22
references.pmid: 16254258
references.citation: J Allergy Clin Immunol. 2005 Apr;115(4):828-33
references.pmid: 15806006
references.citation: J Exp Med. 2000 May 1;191(9):1499-512
references.pmid: 10790425
references.citation: Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15661-8
references.pmid: 12441397
references.citation: Immunology. 2005 Jan;114(1):112-20
references.pmid: 15606801
references.citation: Am J Pediatr Hematol Oncol. 1993 May;15(2):208-18
references.pmid: 8498644